Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
EW Edwards Lifesciences	$85.93 +0.2%	$81.42	$72.30 ▼ $87.89	$49.48B	0.87	5.09 million shs	4.94 million shs
ISRG Intuitive Surgical	$438.10	$458.62	$417.74 ▼ $603.88	$155.16B	1.51	2.22 million shs	2.01 million shs
PFE Pfizer	$25.92 +0.1%	$26.86	$22.88 ▼ $28.75	$147.72B	0.35	37.77 million shs	22.30 million shs
SYK Stryker	$316.39 0.0%	$325.22	$281.00 ▼ $404.87	$121.29B	0.8	2.99 million shs	1.89 million shs

Options Trading Made Easy - Download Now

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
EW Edwards Lifesciences	0.00%	+5.64%	+2.05%	+4.10%	+14.60%
ISRG Intuitive Surgical	0.00%	+4.03%	-9.15%	-10.97%	-18.80%
PFE Pfizer	0.00%	+2.41%	-4.03%	-4.13%	+11.08%
SYK Stryker	0.00%	+3.15%	-3.49%	-17.78%	-16.08%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
EW Edwards Lifesciences	$85.93 +0.2%	$81.42	$72.30 ▼ $87.89	$49.48B	0.87	5.09 million shs	4.94 million shs
ISRG Intuitive Surgical	$438.10	$458.62	$417.74 ▼ $603.88	$155.16B	1.51	2.22 million shs	2.01 million shs
PFE Pfizer	$25.92 +0.1%	$26.86	$22.88 ▼ $28.75	$147.72B	0.35	37.77 million shs	22.30 million shs
SYK Stryker	$316.39 0.0%	$325.22	$281.00 ▼ $404.87	$121.29B	0.8	2.99 million shs	1.89 million shs

Options Trading Made Easy - Download Now

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
EW Edwards Lifesciences	0.00%	+5.64%	+2.05%	+4.10%	+14.60%
ISRG Intuitive Surgical	0.00%	+4.03%	-9.15%	-10.97%	-18.80%
PFE Pfizer	0.00%	+2.41%	-4.03%	-4.13%	+11.08%
SYK Stryker	0.00%	+3.15%	-3.49%	-17.78%	-16.08%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
EW Edwards Lifesciences	2.79	Moderate Buy	$95.65	11.31% Upside
ISRG Intuitive Surgical	2.67	Moderate Buy	$579.33	32.24% Upside
PFE Pfizer	2.19	Hold	$28.61	10.39% Upside
SYK Stryker	2.73	Moderate Buy	$395.48	25.00% Upside

Current Analyst Ratings Breakdown

Latest ISRG, EW, SYK, and PFE Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
5/19/2026	ISRG Intuitive Surgical	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Hold (C)
5/18/2026	ISRG Intuitive Surgical	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Buy	$650.00 ➝ $520.00
5/14/2026	PFE Pfizer	Wolfe Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Underperform	$26.00
5/6/2026	PFE Pfizer	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Hold (C-) ➝ Hold (C)
5/4/2026	SYK Stryker	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Hold (C+) ➝ Hold (C)
5/4/2026	SYK Stryker	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Hold	$380.00 ➝ $330.00
5/4/2026	SYK Stryker	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Overweight	$469.00 ➝ $394.00
5/1/2026	SYK Stryker	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Neutral	$361.00
5/1/2026	SYK Stryker	Sanford C. Bernstein Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target		$410.00
5/1/2026	SYK Stryker	Robert W. Baird Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target		$385.00
5/1/2026	SYK Stryker	Evercore Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target		$355.00

(Data available from 5/25/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
EW Edwards Lifesciences	$6.07B	8.15	$2.86 per share	30.08	$17.94 per share	4.79
ISRG Intuitive Surgical	$10.06B	15.42	$9.28 per share	47.22	$49.69 per share	8.82
PFE Pfizer	$62.58B	2.36	$4.40 per share	5.89	$15.86 per share	1.63
SYK Stryker	$25.12B	4.83	$16.88 per share	18.74	$59.94 per share	5.28

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
EW Edwards Lifesciences	$1.07B	$1.88	45.71	25.57	2.15	17.39%	15.19%	11.71%	7/23/2026 (Estimated)
ISRG Intuitive Surgical	$2.86B	$8.25	53.10	44.66	3.50	28.15%	15.98%	14.07%	7/28/2026 (Estimated)
PFE Pfizer	$7.77B	$1.31	19.79	9.06	N/A	11.83%	19.44%	8.41%	8/4/2026 (Estimated)
SYK Stryker	$3.25B	$8.64	36.62	19.03	1.99	13.20%	23.42%	11.04%	7/30/2026 (Estimated)

Latest ISRG, EW, SYK, and PFE Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
5/5/2026	Q1 2026	PFE Pfizer	$0.7220	$0.75	+$0.0280	$0.47	$13.84 billion	$14.45 billion
4/30/2026	Q1 2026	SYK Stryker	$2.98	$2.60	-$0.38	$1.93	$6.34 billion	$6.02 billion
4/23/2026	Q1 2026	EW Edwards Lifesciences	$0.7280	$0.78	+$0.0520	$0.66	$1.60 billion	$1.65 billion
4/21/2026	Q1 2026	ISRG Intuitive Surgical	$2.08	$2.50	+$0.42	$2.28	$2.62 billion	$2.77 billion

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
EW Edwards Lifesciences	N/A	N/A	N/A	N/A	N/A
ISRG Intuitive Surgical	N/A	N/A	N/A	N/A	N/A
PFE Pfizer	$1.72	6.64%	-13.20%	131.30%	16 Years
SYK Stryker	$3.52	1.11%	+7.58%	40.74%	32 Years

Latest ISRG, EW, SYK, and PFE Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
5/6/2026	SYK Stryker	quarterly	$0.88	1.2%	6/30/2026	6/30/2026	7/31/2026
4/22/2026	PFE Pfizer	quarterly	$0.43	6.71%	5/8/2026	5/8/2026	6/12/2026

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
EW Edwards Lifesciences	0.06	4.42	3.63
ISRG Intuitive Surgical	N/A	4.61	3.59
PFE Pfizer	0.67	1.25	0.94
SYK Stryker	0.62	2.11	1.25

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
EW Edwards Lifesciences	79.46%
ISRG Intuitive Surgical	83.64%
PFE Pfizer	68.36%
SYK Stryker	77.09%

Insider Ownership

Company	Insider Ownership
EW Edwards Lifesciences	0.31%
ISRG Intuitive Surgical	0.60%
PFE Pfizer	0.62%
SYK Stryker	4.60%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
EW Edwards Lifesciences	16,000	575.80 million	574.02 million	Optionable
ISRG Intuitive Surgical	17,021	354.16 million	352.04 million	Optionable
PFE Pfizer	75,000	5.70 billion	5.66 billion	Optionable
SYK Stryker	56,000	383.36 million	365.73 million	Optionable

ISRG, EW, SYK, and PFE Headlines

Recent News About These Companies

Legal & General Group Plc Buys 62,817 Shares of Stryker Corporation $SYK

4 hours ago | marketbeat.com

Fisher Asset Management LLC Trims Position in Stryker Corporation $SYK

May 25 at 4:34 AM | marketbeat.com

Stryker Corporation $SYK Shares Sold by Clearstead Trust LLC

May 25 at 4:26 AM | marketbeat.com

Global Retirement Partners LLC Grows Stock Holdings in Stryker Corporation $SYK

May 23 at 5:40 AM | marketbeat.com

Fideuram Intesa Sanpaolo Private Banking S.P.A. Makes New Investment in Stryker Corporation $SYK

May 22 at 3:57 AM | marketbeat.com

Stryker Expands Peripheral Vascular Reach With Amplitude Deal And Undervalued Shares

May 21, 2026 | finance.yahoo.com

Rathbones Group PLC Grows Stock Position in Stryker Corporation $SYK

May 21, 2026 | marketbeat.com

ProShare Advisors LLC Acquires 5,047 Shares of Stryker Corporation $SYK

May 21, 2026 | marketbeat.com

Stryker Announces Chief Accounting Officer Retirement and Successor

May 20, 2026 | tipranks.com

Harvest Portfolios Group Inc. Purchases 15,499 Shares of Stryker Corporation $SYK

May 20, 2026 | marketbeat.com

PNC Financial Services Group Inc. Lowers Stock Position in Stryker Corporation $SYK

May 20, 2026 | marketbeat.com

Stryker Corporation $SYK Stock Position Increased by Atle Fund Management AB

May 20, 2026 | marketbeat.com

Stryker: Investors May Have Overreacted To Q1 Weakness

May 20, 2026 | seekingalpha.com

Is Wall Street Bullish or Bearish on Stryker Corporation Stock?

May 20, 2026 | barchart.com

Resona Asset Management Co. Ltd. Trims Stock Holdings in Stryker Corporation $SYK

May 19, 2026 | marketbeat.com

BioStar Capital-Backed Amplitude Vascular Systems' $835M Acquisition by Stryker Reflects Strength of Michigan's Medtech Ecosystem

May 19, 2026 | businesswire.com

Stryker Corporation $SYK Shares Bought by AMF Tjanstepension AB

May 19, 2026 | marketbeat.com

AVS, Now Part of Stryker, Enrolls First Patient in First-in-Human Coronary Intravascular Lithotripsy Study

May 18, 2026 | businesswire.com

PAHC or SYK: Which Is the Better Value Stock Right Now?

May 18, 2026 | zacks.com

RiverFront Investment Group LLC Sells 4,777 Shares of Stryker Corporation $SYK

May 18, 2026 | marketbeat.com

Is There Now An Opportunity In Stryker (SYK) After Recent Share Price Pullback

May 17, 2026 | finance.yahoo.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

ISRG, EW, SYK, and PFE Company Descriptions

Edwards Lifesciences NYSE:EW

$85.93 +0.15 (+0.17%)

Closing price 05/22/2026 03:59 PM Eastern

Extended Trading

$85.21 -0.72 (-0.84%)

As of 05/22/2026 07:36 PM Eastern

Edwards Lifesciences Corporation provides products and technologies for structural heart disease and critical care monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL PRECISION and Cardioband names. The company also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name; INSPIRIS RESILLA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valves conduit for complex combined procedures; and MITRIS RESILIA valve. In addition, it offers critical care solutions, including hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings under the FloTrac, Acumen IQ sensors, ClearSight, Acumen IQ cuffs, and ForeSight names; HemoSphere, a monitoring platform that displays physiological information; and Acumen Hypotension Prediction Index software that alerts clinicians in advance of a patient developing dangerously low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.

Intuitive Surgical NASDAQ:ISRG

$438.10 0.00 (0.00%)

Closing price 05/22/2026 04:00 PM Eastern

Extended Trading

$437.33 -0.77 (-0.18%)

As of 05/22/2026 08:00 PM Eastern

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. The company sells its products through direct sales organizations, such as capital and clinical sales teams. It has a collaboration agreement with FluoGuide A/S for head & neck cancer. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.

Pfizer NYSE:PFE

$25.92 +0.02 (+0.07%)

Closing price 05/22/2026 03:59 PM Eastern

Extended Trading

$25.91 -0.01 (-0.03%)

As of 05/22/2026 07:59 PM Eastern

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Stryker NYSE:SYK

$316.39 -0.09 (-0.03%)

Closing price 05/22/2026 03:59 PM Eastern

Extended Trading

$316.50 +0.11 (+0.03%)

As of 05/22/2026 07:59 PM Eastern

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical and thoracolumbar systems that include fixation, minimally invasive and interbody systems used in spinal injury, complex spine and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment, and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, clinical communication and workflow solutions, and other medical device products that are used in various medical specialties, as well as patient and caregiver safety technologies. This segment also provides neurosurgical, neurovascular and craniomaxillofacial implant products, which include products used for minimally invasive endovascular procedures; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest ISRG, EW, SYK, and PFE Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest ISRG, EW, SYK, and PFE Earnings

Compare Dividends

Latest ISRG, EW, SYK, and PFE Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

ISRG, EW, SYK, and PFE Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

ISRG, EW, SYK, and PFE Company Descriptions

Edwards Lifesciences NYSE:EW

Intuitive Surgical NASDAQ:ISRG

Pfizer NYSE:PFE

Stryker NYSE:SYK

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools